Status:
COMPLETED
Non-Interventional Study About Treatment of Hemorrhages in Thyroid Surgery With TachoSil®
Lead Sponsor:
Nycomed
Conditions:
Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
Considering the total number of thyroid procedures in Germany (100000 - 120000 cases per year), TachoSil® is a valuable tool to support surgical haemostasis, avoiding lymph leaks and support speech-ne...
Eligibility Criteria
Inclusion
- Main
- Patients undergoing total or subtotal thyroidectomy
- Main
Exclusion
- Contraindications, such as hypersensitivity to the active pharmaceutical ingredient or to another ingredient
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
482 Patients enrolled
Trial Details
Trial ID
NCT00700141
Start Date
September 1 2008
End Date
January 1 2009
Last Update
May 8 2012
Active Locations (132)
Enter a location and click search to find clinical trials sorted by distance.
1
Nycomed Deutschland GmbH
Aschaffenburg, Germany, 63739
2
Nycomed Deutschland GmbH
Aschersleben, Germany, 06449
3
Nycomed Deutschland GmbH
Bad Berka, Germany, 99437
4
Nycomed Deutschland GmbH
Bad Salzungen, Germany, 36433